NeuroOne Medical Technologies Corporation Q1 2026 Earnings Call Summary
Yahoo Finance·2026-02-17 17:32
The 1RF brain ablation system saw significant adoption momentum, with nearly half of all historical ablations occurring within the first fiscal quarter of 2026. The 1RF trigeminal nerve ablation system entered a limited commercial launch, demonstrating a competitive advantage by requiring only a single probe placement compared to traditional multiple-placement systems. Management accelerated the drug delivery program by approximately six months, with devices now expected to be available for investigat ...